BioSpace News Archive

Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”) today announced that it has signed a new three-year agreement with Boston IVF, a pioneer in reproductive healthcare and innovative research and one of the world’s most experienced fertility treatment providers.

Outset Medical, Inc. today announced that members of management will participate in fireside chats at two upcoming investor conferences.

Syntr Health Technologies, Inc. announces positive interim results from its post-market facial fat transfer clinical study.

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced the initiation of the ReMMi-D, Reduction in Monthly Migraine Days study, a fully remote and decentralized pivotal trial designed to investigate the efficacy and safety of prescription digital therapeutics in reducing the number of monthly migraine days for adults diagnosed with episodic migraine.

Abbott (NYSE: ABT) today announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company’s industry-leading life support system.

Neurelis, Inc. will present four posters from the completed long-term, open-label, repeat-dose safety study of VALTOCO for the treatment of episodes of frequent seizure activity (i.e., seizure clusters) in patients with epilepsy ages 6 to 65 years.

Endonovo Therapeutics, Inc. (OTCQB: ENDV), a leading developer of medical technologies, today announced it is moving forward in its clinical development in the field of Traumatic Brain Injury (TBI) treatment.

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced the opening of a clinical trial to study its investigational Tri-Ad5 vaccine combination (Adenovirus 5 CEA/MUC1/brachyury) together with its IL-15 superagonist N-803, an immune-enhancer, for people with a hereditary condition known as Lynch syndrome.

Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce CPC’s new AseptiQuik® W Series connectors to its extensive line of aseptic genderless connectors.

CANAQUEST MEDICAL CORP. (OTC PINK:CANQF) (the “Company” or “CanaQuest”) today announced the signing of a Master Service Agreement with Neeka Health (“Neeka”) that will encompass multiple clinical studies to evaluate the efficacy of Mentanine® on targeted populations struggling with transitional issues.